Vascular endothelial growth factor (VEGF) and tissue inhibitor of metalloproteinase-1 (TIMP-1) are involved in these processes and might therefore serve as potential biomarkers in ovarian cancer patients [15,16]. The gene discussed is TIMP1; the disease is ovarian carcinoma.